← All diseases
Cancer
Lung cancer (small cell)
Do you want to receive a message when there is new research about Small Cell Lung Cancer (SCLC)? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, above every publication you see one sentence explaining what was studied — and you'll be notified as soon as there is new research about Small cell lung cancer. View what Premium costs.
Publications and studies (3320)
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. [Fulminant hypercorticism due to ACTG producing pheochromocytoma]. (2023/11/02) ♡
- Impact of systemic inflammatory markers in patients with ALK-positive non-small cell lung cancer treated with crizotinib. (2023/11/01) ♡
- The clinical application of atorvastatin in patients with small-cell lung cancer with dyslipidemia. (2023/11/01) ♡
- Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. The negative effect of concomitant medications on immunotherapy in non-small cell lung cancer: An umbrella review. (2023/11/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. The DC-T cell axis is an effective target for the treatment of non-small cell lung cancer. (2023/11/01) ♡
- A Biodegradable Nucleotide Coordination Polymer for Enhanced NSCLC Therapy in Combination with Metabolic Modulation. (2023/11/01) ♡
- Association between adherence to Eat-Lancet diet and incidence and mortality of lung cancer: A prospective cohort study. (2023/11/01) ♡
- A qualitative stakeholder analysis of beliefs, facilitators, and barriers for a feasible prehabilitation program before lung cancer surgery. (2023/11/01) ♡
- Glucose restriction induces AMPK-SIRT1-mediated circadian clock gene Per expression and delays NSCLC progression. (2023/11/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. FGF23-related hypophosphatemia in a patient with small cell lung cancer: a case report and literature review. (2023/10/30) ♡
- Discussion to: Comprehensive sampling of the lung microbiome in early-stage non-small cell lung cancer. (2023/10/30) ♡
- Efficacy and safety of utidelone for the treatment of patients with locally advanced or metastatic non-small-cell lung cancer who have failed standard second-line treatment: A phase 2 clinical trial (BG01-1801). (2023/10/29) ♡
- Effects of omega-3 fatty acid supplementation on nutritional status and inflammatory response in patients with stage II-III NSCLC undergoing postoperative chemotherapy: a double-blind randomized controlled trial. (2023/10/26) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. The Gut Microbiome from a Biomarker to a Novel Therapeutic Strategy for Immunotherapy Response in Patients with Lung Cancer. (2023/10/24) ♡
- Meta-analysisiAll studies on one question combined and calculated together. This is the strongest form of research that exists: a single loose study can be coincidence, dozens together much less so. The label says something about the design, not about the outcome — which can also be that something does NOT work. Impact of BMI on the survival outcomes of non-small cell lung cancer patients treated with immune checkpoint inhibitors: a meta-analysis. (2023/10/23) ♡
- Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. Acupuncture or moxibustion adjuvant chemotherapy for advanced non-small cell lung cancer: Systematic review and network meta-analysis. (2023/10/20) ♡
- Large-scale exome array summary statistics resources for glycemic traits to aid effector gene prioritization. (2023/10/20) ♡
- Detection of Tumor DNA in Bronchoscopic Fluids in Peripheral NSCLC: A Proof-of-Concept Study. (2023/10/19) ♡
- Comparison of Efficacy and Safety of a Bevacizumab Biosimilar, in Combination with Chemotherapies, in Nonresectable Metastatic Colorectal Cancer and in Advanced Nonsquamous Non-Small Cell Lung Cancer: A Randomized, Double-Blind, Phase III Study. (2023/10/13) ♡
- Meta-analysisiAll studies on one question combined and calculated together. This is the strongest form of research that exists: a single loose study can be coincidence, dozens together much less so. The label says something about the design, not about the outcome — which can also be that something does NOT work. Prognostic significance of blood-based PD-L1 analysis in patients with non-small cell lung cancer undergoing immune checkpoint inhibitor therapy: a systematic review and meta-analysis. (2023/10/11) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Real-world challenges in first-line treatment of metastatic EGFR-mutated non-small cell lung cancer. (2023/10/11) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Immunotherapy in Non-small Cell Lung Cancer: a Review. (2023/10/11) ♡
- Preconditioning program reduces the incidence of prolonged hospital stay after lung cancer surgery: Results from the Move For Surgery randomized clinical trial. (2023/10/10) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Factors associated with early discontinuation of anamorelin in patients with cancer-associated cachexia. (2023/10/10) ♡
- Cucurbitacin E Exerts Anti-Proliferative Activity via Promoting p62-Dependent Apoptosis in Human Non-Small-Cell Lung Cancer A549 Cells. (2023/10/07) ♡
- Meta-analysisiAll studies on one question combined and calculated together. This is the strongest form of research that exists: a single loose study can be coincidence, dozens together much less so. The label says something about the design, not about the outcome — which can also be that something does NOT work. Efficacy and safety of Xiao-ai-ping injection add-on therapy to chemotherapy in patients with non-small cell lung cancer: A systematic review and meta-analysis. (2023/10/06) ♡
- Reduction in gefitinib resistance mediated by Yi-Fei San-Jie pill in non-small cell lung cancer through regulation of tyrosine metabolism, cell cycle, and the MET/EGFR signaling pathway. (2023/10/05) ♡
- Immune checkpoint inhibitors for RET fusion non-small cell lung cancer: hopes and challenges. (2023/10/01) ♡
- USP12 promotes nonsmall cell lung cancer progression through deubiquitinating and stabilizing RRM2. (2023/10/01) ♡
- Target and Mechanism of the Xihuang Pill Based on Network Pharmacology for Lung Squamous Cell Carcinoma. (2023/10/01) ♡
- Blocking LTB (4) signaling-mediated TAMs recruitment by Rhizoma Coptidis sensitizes lung cancer to immunotherapy. (2023/10/01) ♡
- Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. Effects of exercise prehabilitation and/or rehabilitation on health-related quality of life and fatigue in patients with non-small cell lung cancer undergoing surgery: A systematic review. (2023/10/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Endoscopic Ultrasound-Guided Gastrogastrostomy Using Lumen Apposing Metal Stent for Management of High-Grade Gastric Outlet Obstruction Secondary to Vertical Banded Gastroplasty. (2023/10/01) ♡
- Role of prognostic nutritional index in postoperative radiotherapy for non-small cell lung cancer. (2023/10/01) ♡
- Elevated serum lactate dehydrogenase to albumin ratio is a useful poor prognostic predictor of nivolumab in patients with non-small cell lung cancer. (2023/10/01) ♡
- Highlights in non-small cell lung cancer from the IASLC 2023 World Conference on Lung Cancer. (2023/10/01) ♡
- Highlights in non-small cell lung cancer from the IASLC 2023 World Conference on Lung Cancer: commentary. (2023/10/01) ♡
- Role of curcumin in miR-26a and its effect on DNMT1, DNMT3b, and MEG3 expression in A549 lung cancer cell. (2023/10/01) ♡
- Predictors of response in EGFR mutant metastatic non-small cell lung cancer patients treated with tyrosine kinase inhibitors (2023/10/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. A novel EML4-NTRK3 fusion in lung adenocarcinoma with dramatic response to entrectinib. (2023/10/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. A CASE OF HYPONATREMIA DUE TO PITUITARY METASTASIS OR LUNG CANCER. (2023/10/01) ♡
- Interaction between Rum and Epithelial miRNAs microbiota metabolites in Response to Cold-Season Nutritional Stress in Tibetan Sheep. (2023/09/23) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Traditional Chinese medicines for non-small cell lung cancer: Therapies and mechanisms. (2023/09/21) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Impact of PD-1/PD-L1 inhibitors on survival in stage III non-small-cell lung cancer: A systematic review. (2023/09/21) ♡
- Identification of small cell lung cancer patients who are at risk of developing common serious adverse event groups with machine learning. (2023/09/15) ♡
- Combined early palliative care for non-small-cell lung cancer patients: a randomized controlled trial in Chongqing, China. (2023/09/14) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Symptomatic duodenal metastasis from a small cell lung cancer primary: a rare case. (2023/09/14) ♡
- Polygenic risk score for ulcerative colitis predicts immune checkpoint inhibitor-mediated colitis. (2023/09/13) ♡
- The Prognostic Value of the Novel Global Immune-Nutrition-Inflammation Index (GINI) in Stage IIIC Non-Small Cell Lung Cancer Patients Treated with Concurrent Chemoradiotherapy. (2023/09/11) ♡
- Saponin-Derived Silver Nanoparticles from Phoenix dactylifera (Ajwa Dates) Exhibit Broad-Spectrum Bioactivities Combating Bacterial Infections. (2023/09/07) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.